Role of RGS17 in cisplatin-induced cochlear inflammation and ototoxicity via caspase-3 activation
Cisplatin is a chemotherapy drug used to treat different solid tumors, including ovarian, bladder, lung, and head and neck cancers. One of its significant side effects is ototoxicity, especially when high doses are required. Cisplatin-induced ototoxici…